Teva

Latest stories

8h
FOX Business
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016side, these headwinds appear to have created some compelling bargains. For exa
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
FOX Business / Posted 8 hours ago
side, these headwinds appear to have created some compelling bargains. For example, AstraZeneca , Seattle Genetics , and Teva Pharmaceutical Industries Ltd. have all fallen by double digits this year, according to data fromS&P Global Market... Read more
8h
FOX Business
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016side, these headwinds appear to have created some compelling bargains. For exa
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
FOX Business / Posted 8 hours ago
side, these headwinds appear to have created some compelling bargains. For example, AstraZeneca , Seattle Genetics , and Teva Pharmaceutical Industries Ltd. have all fallen by double digits this year, according to data fromS&P Global Market... Read more
8h
Daily Mail
Senator being vetted as a Clinton running mate took $160,000 in giftscommittee, threw him $20,000 for travel expenses. The Democratic Party of Virg
Senator being vetted as a Clinton running mate took $160,000 in gifts
Daily Mail / Posted 8 hours ago
committee, threw him $20,000 for travel expenses. The Democratic Party of Virginia gave Kaine $11,000 toward travel. Teva Pharmaceuticals gave Kaine $12,000 in August of 2006 so that he could attend a Democratic Governors Association meeting... Read more
3 related stories
10h
FOX Business
Chesapeake Partners Shuts Down Citing Government Regulationthis year on Allergan and other companies whose planned mergers were delayed or
Chesapeake Partners Shuts Down Citing Government Regulation
FOX Business / Posted 10 hours ago
this year on Allergan and other companies whose planned mergers were delayed or abandoned, including Office Depot Inc and Teva Pharmaceutical Industries Ltd. "From that moment, it has not been possible to invest in pending mergers in the same... Read more
10h
FOX Business
Chesapeake Partners Shuts Down Citing Government Regulationthis year on Allergan and other companies whose planned mergers were delayed or
Chesapeake Partners Shuts Down Citing Government Regulation
FOX Business / Posted 10 hours ago
this year on Allergan and other companies whose planned mergers were delayed or abandoned, including Office Depot Inc and Teva Pharmaceutical Industries Ltd. "From that moment, it has not been possible to invest in pending mergers in the same... Read more
10h
Daily Telegraph
Individual NHS doctors receiving £100,000 per year from drugs firmsa respiratory specialist at the University of Dundee, who works at NHS Tayside,
Individual NHS doctors receiving £100,000 per year from drugs firms
Daily Telegraph / Posted 10 hours ago
a respiratory specialist at the University of Dundee, who works at NHS Tayside, received £96,647 in fees and expenses from Teva UK. Last night he admitted that he would routinely provide advice on their products in his role advising the formulary... Read more
22h
Brisbane Times
Mayne knocking on the door of ASX100 inclusionPharma is upgrading its US production capacity, which is due to be completed in
Mayne knocking on the door of ASX100 inclusion
Brisbane Times / Posted 22 hours ago
Pharma is upgrading its US production capacity, which is due to be completed in 2018. The drugs are being acquired from Teva and Allergan ahead of the planned merger of the two companies, which has prompted the US government to push for the... Read more
24 related stories
1d
Sky News Australia
Mayne soars following US drug acquisitionsPharma announced this week it would significantly expand its US presence throug
Mayne soars following US drug acquisitions
Sky News Australia / Posted yesterday
Pharma announced this week it would significantly expand its US presence through the generic drug acquisitions from Teva Pharmaceutical Industries and Allergan. Mayne said on Thursday that it had raised about $347 million under the... Read more
24 related stories
1d
Herald Sun
Mayne Pharma institutional offer taken upraising $287 million. The retail component of the retail entitlement offer wil
Mayne Pharma institutional offer taken up
Herald Sun / Posted yesterday
raising $287 million. The retail component of the retail entitlement offer will open on July 4 and closes on July 15, 2016. The funds will be used to acquire 37 approved and 5 FDA filed products from Teva Pharmaceutical Industries and A... Read more
24 related stories
1d
Adelaide Now
Mayne Pharma institutional offer taken upraising $287 million. The retail component of the retail entitlement offer wil
Mayne Pharma institutional offer taken up
Adelaide Now / Posted yesterday
raising $287 million. The retail component of the retail entitlement offer will open on July 4 and closes on July 15, 2016. The funds will be used to acquire 37 approved and 5 FDA filed products from Teva Pharmaceutical Industries and A... Read more
24 related stories
1d
The Courier Mail
Mayne Pharma institutional offer taken upraising $287 million. The retail component of the retail entitlement offer wil
Mayne Pharma institutional offer taken up
The Courier Mail / Posted yesterday
raising $287 million. The retail component of the retail entitlement offer will open on July 4 and closes on July 15, 2016. The funds will be used to acquire 37 approved and 5 FDA filed products from Teva Pharmaceutical Industries and A... Read more
24 related stories
1d
CTV News
'Terrified': Shortage of anti-seizure drug a crisis for patientsApotex provides 70 to 80 per cent of the clobazam sold in Canada, with the rest
'Terrified': Shortage of anti-seizure drug a crisis for patients
CTV News / Posted yesterday
Apotex provides 70 to 80 per cent of the clobazam sold in Canada, with the rest of the market covered by generic drug maker Teva Canada and Lundbeck Canada, which sells the drug under the brand name Frisium. Pro Doc Ltd. sells a private-label brand... Read more
2d
Canberra Times
Mayne Pharma keeps cheque book open for more buysto build its presence in the US. It announced on Monday the purchase of a suit
Mayne Pharma keeps cheque book open for more buys
Canberra Times / Posted 2 days ago
to build its presence in the US. It announced on Monday the purchase of a suite of generic drugs from Israeli drugs outfit Teva Pharmaceutical for $900 million, which is to be funded via share issues, while taking on a further $150 million of debt.... Read more
24 related stories
2d
Brisbane Times
Mayne Pharma keeps cheque book open for more buysto build its presence in the US. It announced on Monday the purchase of a suit
Mayne Pharma keeps cheque book open for more buys
Brisbane Times / Posted 2 days ago
to build its presence in the US. It announced on Monday the purchase of a suite of generic drugs from Israeli drugs outfit Teva Pharmaceutical for $900 million, which is to be funded via share issues, while taking on a further $150 million of debt.... Read more
24 related stories
2d
The Age
Mayne Pharma keeps cheque book open for more buysto build its presence in the US. It announced on Monday the purchase of a suit
Mayne Pharma keeps cheque book open for more buys
The Age / Posted 2 days ago
to build its presence in the US. It announced on Monday the purchase of a suite of generic drugs from Israeli drugs outfit Teva Pharmaceutical for $900 million, which is to be funded via share issues, while taking on a further $150 million of debt.... Read more
24 related stories
2d
Sydney Morning Herald
Mayne Pharma keeps cheque book open for more buysto build its presence in the US. It announced on Monday the purchase of a suit
Mayne Pharma keeps cheque book open for more buys
Sydney Morning Herald / Posted 2 days ago
to build its presence in the US. It announced on Monday the purchase of a suite of generic drugs from Israeli drugs outfit Teva Pharmaceutical for $900 million, which is to be funded via share issues, while taking on a further $150 million of debt.... Read more
24 related stories
2d
WA Today
Mayne Pharma keeps cheque book open for more buysto build its presence in the US. It announced on Monday the purchase of a suit
Mayne Pharma keeps cheque book open for more buys
WA Today / Posted 2 days ago
to build its presence in the US. It announced on Monday the purchase of a suite of generic drugs from Israeli drugs outfit Teva Pharmaceutical for $900 million, which is to be funded via share issues, while taking on a further $150 million of debt.... Read more
24 related stories
2d
Australian Broadcasting Corporation
Energy, mining stocks fall as Brexit continues to spook investorsproposed. In healthcare stocks, and Mayne Pharma is in a trading halt after an
Energy, mining stocks fall as Brexit continues to spook investors
Australian Broadcasting Corporation / Posted 2 days ago
proposed. In healthcare stocks, and Mayne Pharma is in a trading halt after announcing a deal to buy 42 generic drugs from Teva Pharmaceitucal Industries and Allergan. Mayne plans fund the deal by extending an existing debt facility and selling... Read more
2d
Sky News Australia
Mayne Pharma expands into US for $889mexpand its US presence through the $US652 million ($A889 million) acquisition o
Mayne Pharma expands into US for $889m
Sky News Australia / Posted 2 days ago
expand its US presence through the $US652 million ($A889 million) acquisition of a suite of generic drugs from Teva Pharmaceutical Industries and Allergan. Mayne said the price excludes transaction costs and an extra investment of... Read more
24 related stories
2d
Herald Sun
Mayne Pharma buys Teva drugs for $US652mexpand its US presence through the $US652 million ($A889 million) acquisition o
Mayne Pharma buys Teva drugs for $US652m
Herald Sun / Posted 2 days ago
expand its US presence through the $US652 million ($A889 million) acquisition of a suite of generic drugs from Teva Pharmaceutical Industries and Allergan. Mayne said the price excludes transaction costs and an extra investment of... Read more
24 related stories
3d
TheBull
Mayne Pharma buys Teva drugs for $US652mexpand its US presence through the $US652 million ($A889 million) acquisition o
Mayne Pharma buys Teva drugs for $US652m
TheBull / Posted 3 days ago
expand its US presence through the $US652 million ($A889 million) acquisition of a suite of generic drugs from Teva Pharmaceutical Industries and Allergan. Mayne said the price excludes transaction costs and an extra investment of... Read more
24 related stories
3d
Perth Now
Mayne Pharma buys Teva drugs for $US652mexpand its US presence through the $US652 million ($A889 million) acquisition o
Mayne Pharma buys Teva drugs for $US652m
Perth Now / Posted 3 days ago
expand its US presence through the $US652 million ($A889 million) acquisition of a suite of generic drugs from Teva Pharmaceutical Industries and Allergan. Mayne said the price excludes transaction costs and an extra investment of... Read more
24 related stories
3d
Adelaide Now
Mayne Pharma buys Teva drugs for $US652mPharmaceuticals firm Mayne Pharma will acquire a suite of US generic drugs from
Mayne Pharma buys Teva drugs for $US652m
Adelaide Now / Posted 3 days ago
Pharmaceuticals firm Mayne Pharma will acquire a suite of US generic drugs from Teva Pharmaceutical Industries and Allergan for $US652 million ($A889 million). Mayne will undertake a $A601 million share offer and a $A287 million placement to fund... Read more
24 related stories
3d
Weekly Times
Mayne Pharma buys Teva drugs for $US652mPharmaceuticals firm Mayne Pharma will acquire a suite of US generic drugs from
Mayne Pharma buys Teva drugs for $US652m
Weekly Times / Posted 3 days ago
Pharmaceuticals firm Mayne Pharma will acquire a suite of US generic drugs from Teva Pharmaceutical Industries and Allergan for $US652 million ($A889 million). Mayne will undertake a $A601 million share offer and a $A287 million placement to fund... Read more
24 related stories
3d
The Courier Mail
Mayne Pharma buys Teva drugs for $US652mPharmaceuticals firm Mayne Pharma will acquire a suite of US generic drugs from
Mayne Pharma buys Teva drugs for $US652m
The Courier Mail / Posted 3 days ago
Pharmaceuticals firm Mayne Pharma will acquire a suite of US generic drugs from Teva Pharmaceutical Industries and Allergan for $US652 million ($A889 million). Mayne will undertake a $A601 million share offer and a $A287 million placement to fund... Read more
24 related stories
3d
Canberra Times
Mayne Pharma in plunge into US drugs marketits presence in the US drugs market with the $890 million ($US652 million) acqu
Mayne Pharma in plunge into US drugs market
Canberra Times / Posted 3 days ago
its presence in the US drugs market with the $890 million ($US652 million) acquisition of a suite of drugs from Israel's Teva Pharmaceuticals. The buy will be funded by a placement and share issue which will lift Mayne's sharemarket worth by... Read more
24 related stories
3d
Brisbane Times
Mayne Pharma in plunge into US drugs marketits presence in the US drugs market with the $890 million ($US652 million) acqu
Mayne Pharma in plunge into US drugs market
Brisbane Times / Posted 3 days ago
its presence in the US drugs market with the $890 million ($US652 million) acquisition of a suite of drugs from Israel's Teva Pharmaceuticals. The buy will be funded by a placement and share issue which will lift Mayne's sharemarket worth by... Read more
24 related stories
3d
Sydney Morning Herald
Mayne Pharma in plunge into US drugs marketMayne Pharma chief executive Scott Richards is raising $888 million to buy a po
Mayne Pharma in plunge into US drugs market
Sydney Morning Herald / Posted 3 days ago
Mayne Pharma chief executive Scott Richards is raising $888 million to buy a portfolio of generic drugs from Teva Pharmaceuticals. Photo: Supplied Mayne Pharma has moved to lift its presence in the US drugs market with the $890 million ($US652... Read more
24 related stories
3d
Business Wire
UGG and Law Enforcement Unearth Bonanza of Fakesfor both everyday casual lifestyle use and high performance activities. The Com
UGG and Law Enforcement Unearth Bonanza of Fakes
Business Wire / Posted 3 days ago
for both everyday casual lifestyle use and high performance activities. The Company’s portfolio of brands includes UGG®, Teva®, Sanuk®, Ahnu®, and HOKA ONE ONE®. Deckers Brands products are sold in more than 50 countries and territories through... Read more
3d
WA Today
Mayne Pharma in plunge into US drugs marketits presence in the US drugs market with the $890 million ($US652 million) acqu
Mayne Pharma in plunge into US drugs market
WA Today / Posted 3 days ago
its presence in the US drugs market with the $890 million ($US652 million) acquisition of a suite of drugs from Israel's Teva Pharmaceuticals. The buy will be funded by a placement and share issue which will lift Mayne's sharemarket worth by... Read more
24 related stories
3d
The Age
Mayne Pharma in plunge into US drugs marketMayne Pharma chief executive Scott Richards is raising $888 million to buy a po
Mayne Pharma in plunge into US drugs market
The Age / Posted 3 days ago
Mayne Pharma chief executive Scott Richards is raising $888 million to buy a portfolio of generic drugs from Teva Pharmaceuticals. Photo: Supplied Mayne Pharma has moved to lift its presence in the US drugs market with the $890 million ($US652... Read more
24 related stories
3d
Reuters
Mayne Pharma nears deal for Teva assetsA sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusa
Mayne Pharma nears deal for Teva assets
Reuters / Posted 3 days ago
A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Australian pharmaceutical company Mayne Pharma Group Ltd (MYX.AX) is nearing a deal to purchase assets from Teva... Read more
24 related stories
3d
Channel NewsAsia
Mayne Pharma nears deal for Teva assetsREUTERS: Australian pharmaceutical company Mayne Pharma Group Ltd is nearing a
Mayne Pharma nears deal for Teva assets
Channel NewsAsia / Posted 3 days ago
REUTERS: Australian pharmaceutical company Mayne Pharma Group Ltd is nearing a deal to purchase assets from Teva Pharmaceuticals worth around US$600 million, a person familiar with the matter said on Monday. The deal is the last of several large... Read more
24 related stories
3d
Business Standard India
Growth challenges remain for Dr Reddy'shas also re-instilled street's confidence in last few days. Firstly, DRL plans
Growth challenges remain for Dr Reddy's
Business Standard India / Posted 3 days ago
has also re-instilled street's confidence in last few days. Firstly, DRL plans to acquire eight high-value ANDAs that Teva is divesting to close its own acquisition of generic portfolio of Allergan. The acquisition by DRL is positive looking... Read more
5d
KCTV 5 Kansas City
Royals Charities Diamond of Dreams raises record-breaking $350Kwere on-field along with current and former Royals players and band Daughtry.
Royals Charities Diamond of Dreams raises record-breaking $350K
KCTV 5 Kansas City / Posted 5 days ago
were on-field along with current and former Royals players and band Daughtry. Event sponsors for Diamond of Dreams include Teva, Aramark, LMC Truck, BOK Financial, DSS, Inc., Drukan/Mohawk, Edelman & Thompson, Garmin, HB Trucking, Kansas City Steak... Read more
5d
Kansas City Royals
Royals charities celebrates record-setting proceeds for Diamond of DreamsProceeds from ticket sales, the Teva Silent Auction, a Rolex watch raffle court
Royals charities celebrates record-setting proceeds for Diamond of Dreams
Kansas City Royals / Posted 5 days ago
Proceeds from ticket sales, the Teva Silent Auction, a Rolex watch raffle courtesy of TIVOL and an exclusive Tiffany & Co. "Mystery Box" experience, raised more than $350,000 to fund Royals Charities military partners, including Folds of Honor,... Read more
6d
ESPN
Sports Misery Index: Cleveland passes its crowntitle: Chargers, 1963 And then, rising above (or below) the fray, it's ... San
Sports Misery Index: Cleveland passes its crown
ESPN / Posted 6 days ago
title: Chargers, 1963 And then, rising above (or below) the fray, it's ... San Diego? Indeed, it's San Diego and its tan, Teva-ed denizens who inherit Cleveland's title as the longest-suffering fans in sports. With the Padres in last place in the... Read more
6d
Business Wire
Teva Receives CHMP Positive Opinion for CINQAERO® (reslizumab)JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
Teva Receives CHMP Positive Opinion for CINQAERO® (reslizumab)
Business Wire / Posted 6 days ago
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing... Read more
6d
Business Wire
Sosei Appoints Peter Bains as CEOrevenue streams that enable further growth. Sosei partners include Novartis, Al
Sosei Appoints Peter Bains as CEO
Business Wire / Posted 6 days ago
revenue streams that enable further growth. Sosei partners include Novartis, Allergan, AstraZeneca, MedImmune, MorphoSys, Teva, and Pfizer and we are actively looking for new partnerships to enhance the development of our products and help us... Read more
7d
FOX Business
Valeant Pharmaceuticals International, Inc. vs. Allerganview beneath the surface isn't quite as pretty. Allergan's planned $40 billion-
Valeant Pharmaceuticals International, Inc. vs. Allergan
FOX Business / Posted 7 days ago
view beneath the surface isn't quite as pretty. Allergan's planned $40 billion-plus sale of its generics segment to Teva Pharmaceutical Industriesmight put a heap of cash in its coffers any day now, butthe sale would leave it with operations... Read more
7d
FOX Business
Valeant Pharmaceuticals International, Inc. vs. Allerganview beneath the surface isn't quite as pretty. Allergan's planned $40 billion-
Valeant Pharmaceuticals International, Inc. vs. Allergan
FOX Business / Posted 7 days ago
view beneath the surface isn't quite as pretty. Allergan's planned $40 billion-plus sale of its generics segment to Teva Pharmaceutical Industriesmight put a heap of cash in its coffers any day now, butthe sale would leave it with operations... Read more
8d
The Financial Express
Govt’s pharma FDI sop may hit affordable healthcareHealthcare by Abbott Inc (US), Matrix Labs by Mylan (US), Shantha Biotech by Sa
Govt’s pharma FDI sop may hit affordable healthcare
The Financial Express / Posted 8 days ago
Healthcare by Abbott Inc (US), Matrix Labs by Mylan (US), Shantha Biotech by Sanofi (France), J K Drugs and Pharmaceuticals by Teva (Israel), injectable business of Orchid Chemicals by Hospira (US) and some popular brands of Universal Caps by San... Read more
8d
MedCity News
Highmark may sell its vision business to offset insurance lossesgovernment in an attempt to recover those funds. — The Wall Street Journal Imp
Highmark may sell its vision business to offset insurance losses
MedCity News / Posted 8 days ago
government in an attempt to recover those funds. — The Wall Street Journal Impax has agreed to purchase generic drugs from Teva and Allergan in a $568 million deal that will allow the Federal Trade Conmission to greenlight Teva’s and Allergan’s... Read more
9d
TribLIVE
U.S. stock market holds steady ahead of Brexit votemaker Impax Laboratories tumbled after it agreed to pay $586 million for a grou
U.S. stock market holds steady ahead of Brexit vote
TribLIVE / Posted 9 days ago
maker Impax Laboratories tumbled after it agreed to pay $586 million for a group of generic drugs owned by Allergan and Teva Pharmaceutical Industries. Those companies had to sell the products because Allergan is buying Teva's generic drugs... Read more
501 related stories
9d
FOX Business
Is Opko Health a Buy Now That Rayaldee Is Approved?Frost, whose resume includes successfully building Ivax Labs into a major gener
Is Opko Health a Buy Now That Rayaldee Is Approved?
FOX Business / Posted 9 days ago
Frost, whose resume includes successfully building Ivax Labs into a major generic drugmaker. Frost sold Ivax Labs to Teva Pharmaceuticalin 2005 for $7.4 billion and served as Teva Pharmaceutical's chairman until stepping down in 2014 to run... Read more
9d
FOX Business
Is Opko Health a Buy Now That Rayaldee Is Approved?Frost, whose resume includes successfully building Ivax Labs into a major gener
Is Opko Health a Buy Now That Rayaldee Is Approved?
FOX Business / Posted 9 days ago
Frost, whose resume includes successfully building Ivax Labs into a major generic drugmaker. Frost sold Ivax Labs to Teva Pharmaceuticalin 2005 for $7.4 billion and served as Teva Pharmaceutical's chairman until stepping down in 2014 to run... Read more
9d
FOX Business
Why Impax Laboratories, Werner Enterprises, and Planet Fitness Slumped Todayafter announcing a deal to purchase a portfolio of generic products from some o
Why Impax Laboratories, Werner Enterprises, and Planet Fitness Slumped Today
FOX Business / Posted 9 days ago
after announcing a deal to purchase a portfolio of generic products from some of its competitors. The agreement involves Teva Pharmaceutical Industries and Allergan and covers 15 currently marketed generics. The $586 million deal also includes... Read more
3 related stories
9d
FOX Business
Why Impax Laboratories, Werner Enterprises, and Planet Fitness Slumped Todayafter announcing a deal to purchase a portfolio of generic products from some o
Why Impax Laboratories, Werner Enterprises, and Planet Fitness Slumped Today
FOX Business / Posted 9 days ago
after announcing a deal to purchase a portfolio of generic products from some of its competitors. The agreement involves Teva Pharmaceutical Industries and Allergan and covers 15 currently marketed generics. The $586 million deal also includes... Read more
3 related stories
9d
Belfast Telegraph
Federal Reserve boss eases tensions on Wall StreetImpax Laboratories tumbled after it agreed to pay 586 million US dollars for a
Federal Reserve boss eases tensions on Wall Street
Belfast Telegraph / Posted 9 days ago
Impax Laboratories tumbled after it agreed to pay 586 million US dollars for a group of generic drugs owned by Allergan and Teva Pharmaceutical Industries. Those companies had to sell the products because Allergan is buying Teva's generic drugs... Read more
501 related stories
9d
The Hendersonville Times-News
US stocks rise as Yellen takes careful tone before Congressmaker Impax Laboratories tumbled after it agreed to pay $586 million for a grou
US stocks rise as Yellen takes careful tone before Congress
The Hendersonville Times-News / Posted 9 days ago
maker Impax Laboratories tumbled after it agreed to pay $586 million for a group of generic drugs owned by Allergan and Teva Pharmaceutical Industries. Those companies had to sell the products because Allergan is buying Teva's generic drugs... Read more
501 related stories
More

People in this news